Prof. Dr. ABDURRAHMAN MİTHAT BOZDAYI

Yayın Ağı

Makaleler 37

1. The role of PAGE-B score in predicting the development of hepatocelular cancer in patients with chronic delta hepatitis

KESKİN O., Kalkan C., ÖZTÜRK B., Caliskan A., Sahin H., Gumussoy M., et al.

JOURNAL OF HEPATOLOGY , cilt.78, 2023 (SCI-Expanded, Scopus)

2. FUNCTIONAL CURE WITH LONAFARNIB-BASED THERAPY IN CHRONIC HEPATITIS DELTA

Yurdaydin C., Yurdcu E., Gumussoy M., KESKİN O., Gencdal G., Akyildiz M., et al.

HEPATOLOGY , cilt.76, 2022 (SCI-Expanded, Scopus)

3. Two cases of COVID-19 reinfection in Turkey

AKDEMİR KALKAN İ., Mohammed N. S., ÇINAR G., GÜLTEN E., SARICAOĞLU E. M., KARAHAN Z. C., et al.

Infectious diseases and clinical microbiology (Online) , cilt.3, 2021 (TRDizin) Sürdürülebilir Kalkınma

4. ATA Index: A novel score for predicting fibrosis stage in chronic viral hepatitis

Tugsal H. Y., YÜKSEL S., Kabacam G., Evirgen S., Akan K., AKYÜZ F., et al.

HEPATOLOGY FORUM , sa.1, ss.12-19, 2021 (ESCI)

5. Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan

Husseini A. A., Saeed K. M. I., Yurdcu E., BOZDAYI A. M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.31, sa.9, ss.658-666, 2020 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

6. The role of PNPLA3 (rs738409) cg variant on histological progression of non-alcoholic fatty liver disease

İDİLMAN R., ÖZEN KARATAYLI S. C., KABAÇAM G., SAVAŞ B., ELHAN A. H., BOZDAYI A. M.

Hepatology Forum , cilt.1, sa.3, ss.82-87, 2020 (ESCI, TRDizin)

7. HEV seroprevalence in blood donors in Turkey by two commercial total anti-HEV Ab ELISA kits

Yasar O., Karatayli E., Cengiz G., Kizilpinar M., Yurdcu E., ALBAYRAK DELİALİOĞLU R., et al.

JOURNAL OF MEDICAL VIROLOGY , cilt.91, sa.12, ss.2174-2181, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Epidemiology of blood-borne viral infections in Afghanistan

Husseini A. A., Saeed K. M. I., Yurdcu E., SERTÖZ Ş. R., BOZDAYI A. M.

ARCHIVES OF VIROLOGY , cilt.164, sa.8, ss.2083-2090, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Evaluation of the results of MOTAKK hepatitis C virus RNA genotyping and hepatitis delta virus external quality assessment programs during 2015-2016

Karatayli E., Soydemir E., Aksoy Z. B., Kizilpinar M., Kocak A. A., Karatayli S. C., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.30, sa.11, ss.957-963, 2019 (SCI-Expanded, Scopus, TRDizin)

10. Evaluation of 2015-2016 MOTAKK HBV DNA and HCV RNA External Quality Assessment National Program Results

Karatayli E., Soydemir E., Aksoy Z. B., Kizilpinar M., Altay Kocak A., Karatayli S. C., et al.

MIKROBIYOLOJI BULTENI , cilt.52, sa.4, ss.348-366, 2018 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

11. Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study

Yurdaydin C., Keskin O., Kalkan C., Karakaya F., Caliskan A., Karatayli E., et al.

HEPATOLOGY , sa.4, ss.1224-1236, 2018 (SCI-Expanded, Scopus)

12. Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-up

Karakaya F., Ozer S., Kalkan C., Tuzun E. A., Caliskan A., Keskin O., et al.

ANTIVIRAL THERAPY , sa.7, ss.559-570, 2017 (SCI-Expanded, Scopus)

13. Interleukin-28 gene polymorphisms may contribute to HBsAg persistence and the development of HBeAg-negative chronic hepatitis B

Karatayli S. C., Bozdayi M., Karatayli E., ÖZTÜRK T., Husseini A. A., ALBAYRAK DELİALİOĞLU R., et al.

LIVER INTERNATIONAL , cilt.35, sa.3, ss.846-853, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Investigation of West Nile virus among healthy blood donors in the western part of Turkey

ULUER BİÇEROĞLU S., Karatayli E., Bayram A., TURHAN A., DEĞİRMENCİ DÖŞKAYA A., AYDINOK Y., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.45, sa.1, ss.84-88, 2015 (SCI-Expanded, Scopus, TRDizin)

15. Free circulating nucleic acids in plasma and serum as a novel approach to the use of internal controls in real time PCR based detection

Karatayli E., Altunoglu Y. C., Karatayli S. C., Yurdaydin C., BOZDAYI A. M.

JOURNAL OF VIROLOGICAL METHODS , cilt.207, ss.133-137, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: Performance of phylogenetic analysis of the NS5B, E1, and 5 ' UTR regions in genotyping efficiency

Alagoz G. K., Karatayli S. C., Karatayli E., Celik E., Keskin O., Dinc B., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.25, sa.4, ss.405-410, 2014 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

17. Production of a Recombinant CagA Protein for the Detection of Helicobacter pylori CagA Antibodies

Akguc M., Karatayli E., Celik E., Koyuncu D., Celik I., Karatayli S. C., et al.

MIKROBIYOLOJI BULTENI , cilt.48, sa.3, ss.402-412, 2014 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

18. A one step real time PCR method for the quantification of hepatitis delta virus RNA using an external armored RNA standard and intrinsic internal control

Karatayli E., Altunoglu Y. C., Karatayli S. C., Alagoz S. G. K., ÇINAR K., YALÇIN K., et al.

JOURNAL OF CLINICAL VIROLOGY , cilt.60, sa.1, ss.11-15, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B

Keskin O., Ormeci A. C., Baran B., Kabacam G., Tuzun A., Karatayli E., et al.

ANTIVIRAL THERAPY , cilt.19, sa.6, ss.543-550, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Clonal analysis of the quasispecies of antiviralresistant HBV genomes in patients with entecavir resistance during rescue treatment and successful treatment of entecavir resistance with tenofovir

Karatayli E., İDİLMAN R., Karatayli S. C., Cevik E., Yakut M., Seven G., et al.

Antiviral Therapy , cilt.18, sa.1, ss.77-85, 2013 (SCI-Expanded, Scopus)

21. Importance of serum SELDI-TOF-MS analysis in the diagnosis of early lung cancer

Şimşek C., Sónmez Ó., YURDAKUL A. S., Ózmen F., Zengin N., Keyf A. I., et al.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.3, ss.2037-2042, 2013 (SCI-Expanded, Scopus)

22. The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country

Toy M., ÖNDER F. O., İDİLMAN R., Kabacam G., Richardus J. H., Bozdayi M., et al.

EUROPEAN JOURNAL OF HEALTH ECONOMICS , cilt.13, sa.5, ss.663-676, 2012 (SSCI, Scopus)

23. Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis

Kabaçam G., Dalekos G. N., Ca̧kaloǧlu Y., Zachou K., Bock T., Erhardt A., et al.

Turkish Journal of Gastroenterology , cilt.23, sa.5, ss.560-568, 2012 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

24. Entecavir treatment of chronic hepatitis D

Kabaçam G., Önder F. O., Yakut M., Seven G., Karatayli S. C., Karatayli E., et al.

Clinical Infectious Diseases , cilt.55, sa.5, ss.645-650, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Molecular characterization of a novel entecavir mutation pattern isolated from a multi-drug refractory patient with chronic hepatitis B infection

Karatayli E., Karatayli S. C., ÇINAR K., GÖKAHMETOĞLU S., GÜVEN K., İDİLMAN R., et al.

Journal of Clinical Virology , cilt.53, sa.2, ss.130-134, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. Effect of Turkish propolis extracts on proteome of prostate cancer cell line

Barlak Y., DEĞER O., Çolak M., Karatayli S. C., BOZDAYI A. M., BALABAN YÜCESAN F.

Proteome Science , cilt.9, 2011 (SCI-Expanded, Scopus)

27. Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D

Seven G., Karatayli S. C., KÖSE S. K., Yakut M., Kabacam G., TÖRÜNER M., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.22, sa.3, ss.305-314, 2011 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

28. Genotype A2/adw2 strain of hepatitis B virus in Turkey: A case report

SAYAN M., Akhan S. C., Bozdayi M.

Hepatitis Monthly , cilt.10, sa.4, ss.302-305, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Effects of polymorphism in G2677T/A triallelic region of MDR1 gene in Turkish patients with inflammatory bowel disease

Sapmaz A., Karatayli S. C. O., Dagli U., Kilic Z. M. Y., TÖRÜNER M., Celik Y., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.19, sa.3, ss.168-173, 2008 (SCI-Expanded, Scopus, TRDizin)

30. Antimicrobial and antiviral screening of novel indole carboxamide and propanamide derivatives

Oelgen S., Altanlar N., Karatayli E., Bozdayi M.

ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES , cilt.63, sa.3-4, ss.189-195, 2008 (SCI-Expanded, Scopus)

31. Biliary lipid secretion

Hismiogullari A. A., BOZDAYI A. M., Rahman K.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.18, sa.2, ss.65-70, 2007 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

32. Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis

Tasci I., Mas M. R., Vural S., Deveci S., Comert B., Alcigir G., et al.

WORLD JOURNAL OF GASTROENTEROLOGY , cilt.13, sa.23, ss.3237-3244, 2007 (SCI-Expanded, Scopus)

33. Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease.

TÖRÜNER M., Erkan Ö., Soykan I., Bozdayi M., Çetinkaya H., Yurdaydin C., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.15, sa.4, ss.250-2, 2004 (Scopus, TRDizin)

34. The mutations in ISDR of NS5A gene are not associated with response to interferon treatment in Turkish patients with chronic hepatitis C virus genotype 1b infection

Aslan N., BOZDAYI A. M., Çetinkaya H., Sarioǧlu M., Türkay C., Bozkaya H., et al.

Turkish Journal of Gastroenterology , cilt.15, sa.1, ss.21-26, 2004 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

35. Interferon-alpha(2b) induction treatment with or without ribavirin in chronic hepatitis C - A multicenter, randomized, controlled trial

Senturk H., Ersoz G., Ozaras R., Kaymakoglu S., Bozkaya H., Akdogan M., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.48, sa.6, ss.1124-1129, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: Their relations to HBeAg status and the activity of liver disease

Bozkaya H., Bozdayi M., Turkyilmaz R., Sarioglu M., Cetinkaya H., Cinar K., et al.

HEPATO-GASTROENTEROLOGY , cilt.47, sa.36, ss.1675-1679, 2000 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. Is there any relationship between Behcet's disease and hepatitis C virus? Behcet hastaligi ve hepatit C virusu arasinda bir iliski var mi?

Uzunalimoglu O., Bozkaya H., Cetinkaya H., BOZDAYI A. M., Yurdaydin C., Erdi H., et al.

Turkish Journal of Gastroenterology , cilt.9, sa.1, ss.10-13, 1998 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 21

1. COVID-19 Pandemisi Başlangıcında SARS-CoV-2 RNA Moleküler Tanısı İçin Motakk Dış Kalite Kontrol (DKK) Programı Değerlendirmesi : Türkiye'de Haftalık - Aylık Yapılan İlk 16 Döngünün Sonuçları

BOZDAYI A. M., DEMİR T., BAYRAKTAR F., ESİN Ö., TURAN M., TÜRKYILMAZ A. R., et al.

7. Ulusal Klinik Mikrobiyoloji Kongresi, Muğla, Türkiye, 01 Kasım 2023, (Özet Bildiri)

2. Viral Seroloji Testleri için Dış Kalite Kontrol (DKK) Programlarının Tasarlanması, Panel Numunelerinin Geliştirilmesi ve Pilot Çalışma Sonuçları

BEHNEJAD KAZANCIK A., TÜRKYILMAZ A. R., ESİN Ö., TAŞDAN T. B., BOZDAYI A. M., ÖCAL D., et al.

7. Ulusal Klinik Mikrobiyoloji Kongresi, Muğla, Türkiye, 01 Kasım 2023, (Özet Bildiri)

3. TREATMENT DISCONTINUATION IN HBEAG-NEGATIVE CHRONIC HEPATIT B IS A VIABLE OPTION IN NON-CIRRHOTIC GENOTYPE D CHRONIC HEPATITIS B PATIENTS

ŞAH ÜNAL F. T., Keskin O., Yurdcu E., Yilmaz Y., KARAKAYA M. F., Kartal A., et al.

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, Amerika Birleşik Devletleri, 8 - 12 Kasım 2019, cilt.70, (Özet Bildiri) Sürdürülebilir Kalkınma

4. 10 YILLIK PROSPEKTİF ÇALIŞMADA DÜŞÜK VİRAL YÜKLÜ HBV TAŞIYICILARI REAKTİVASYONDAN ZİYADE HBSAG KAYBETMEYE YATKINDIR.

KESKİN O., YAKUT M., YURDCU E., KALKAN Ç., AGAYEVA S., YILMAZ Y., et al.

12. ULUSAL HEPATOLOJİİ KONGRESİ, Antalya, Türkiye, 1 - 05 Mayıs 2019, (Özet Bildiri)

5. HEV seroprevalence in blood donors in Turkey: Comparison of two commercial anti-HEV total Ab ELISA kit

Yasar O., Cengiz G., Karatayli E., Kizilpinar M., Yurdcu E., ALBAYRAK DELİALİOĞLU R., et al.

International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Avusturya, 10 - 14 Nisan 2019, cilt.70, (Özet Bildiri)

6. Frequency, severity and impact of Peg-IFNa-associated flares in HDV infection: Results from the HIDIT-II study

Hardtke S., Wedemeyer H., Caruntu F. A., Curescu M., Kendal Y., AKARCA U. S., et al.

International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Avusturya, 10 - 14 Nisan 2019, cilt.70, (Özet Bildiri)

7. Comparison of the efficacy of short term and long term nucleos(t)ide analog treatment in chronic delta hepatitis

YURTAYDIN S. C., KESKİN O., KARAKAYA M. F., YILMAZ Y., ÇALIŞKAN KARTAL A., MELEKOĞLU ELLİK Z., et al.

35. ULUSAL GASTROENTEROLOJİ HAFTASI, Antalya, Türkiye, 21 Kasım 2018, (Özet Bildiri)

8. Nonnvasve Fbross Scores Are Not Useful for Predcton of Response to Treatment n Chronc Delta Hepatts

KESKİN O., YURDCU E., KALKAN Ç., ÇALIŞKAN KARTAL A., ELLİK Z., BOZDAYI A. M., et al.

AASLD LIVER MEETING 2018, San-Francisco, Kostarika, 9 - 13 Kasım 2018, (Özet Bildiri)

9. Noninvasive Fibrosis Scores Are Not Useful for Prediction of Response to Treatment in Chronic Delta Hepatitis

Keskin O., Yurdcu E., Kalkan C., Kartal A., Ellik Z., Bozdayi M., et al.

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68, (Özet Bildiri) Sürdürülebilir Kalkınma

10. The Role Of Genetic Variability Of PNPLA3 (rs738409) On Predispotion To Non-Alcoholic Fatty Liver Disease In Lean Patients

İDİLMAN R., Karatayli S. C., Karakaya F., Keskin O., Gozukara B., SAVAŞ B., et al.

67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64, (Özet Bildiri)

11. The Prenylation Inhibitor Lonafarnib Can Induce Post-Treatment Alt Flares With Viral Clearance In Patients With Chronic Delta Hepatitis

Yurdaydin C., İDİLMAN R., Kalkan C., Karakaya F., Kartal A. C., Keskin O., et al.

67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64, (Özet Bildiri)

12. Exploring Optimal Dosing Of Lonafarnib With Ritonavir For The Treatment Of Chronic Delta Hepatitis-Interim Results From The Lowr Hdv-2 Study

Yurdaydin C., İDİLMAN R., Kalkan C., Karakaya F., Kartal A. C., Keskin O., et al.

67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64, (Özet Bildiri)

13. Hepatitis delta virus kinetics under the prenylation inhibitor lonafarnib suggest HDV metiadted suppression of HBV replication

YURTAYDIN S. C., Borochov N., KALKAN Ç., BedRoy S., KARATAYLI E., HaynesWilliams V., et al.

51th Annual Meeting of the European Association for the Study of the Liver (EASL), 13 - 17 Nisan 2016 Sürdürülebilir Kalkınma

14. The role of genetic variability of pnpla3 rs738409 on histological progression of non alcoholic fatty liver disease

İDİLMAN R., KESKİN O., ÖZEN KARATAYLI S. C., KABAÇAM G., TÜZÜN A. E., SAVAŞ B., et al.

24th Annual Conference of APASL, March 12–15, 2015, Istanbul, Turkey, 12 - 15 Mart 2015, cilt.9, ss.373, (Özet Bildiri)

15. Effectiveness and safety of entecavir and tenofovir in chronic hepatitis b patients: A multicenter Turkish study in clinical practice

İDİLMAN R., GÜNŞAR F., Keskin O., Meral C. E., KORUK M., GÜLŞEN M. T., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri) Sürdürülebilir Kalkınma

16. Inactive hepatitis B carriers are prone to HBsAg loss rather than reactivation: a 5-year prospective follow-up study

Keskin O., Yakut M., Kalkan C., Karatayli S. C., Karatayli E., İDİLMAN R., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri) Sürdürülebilir Kalkınma

17. Interleukin 23 Receptor, and ATG16L1 Gene Polymorphisms in Inflammatory Bowel Diseases, and the Association With the Clinical Course

Kabacam G., Karatayli S. C., Keskin O., Bektas M., Cetinkaya H., Palabiyikoglu M., et al.

Digestive Disease Week (DDW), California, Amerika Birleşik Devletleri, 19 - 22 Mayıs 2012, cilt.142, (Özet Bildiri)

18. INTERLEUKIN-28 (IL-28) GENE POLYMORPHISM (RS12979860 C/T) IS ASSOCIATED WITH PROGRESSION TO CHRONIC DELTA HEPATITIS INFECTION

BOZDAYI A. M., ÖZTÜRK T., Altuntas S., Karatayli S. C., Karatayli E., Celik I., et al.

62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 4 - 08 Kasım 2011, cilt.54, (Özet Bildiri) Sürdürülebilir Kalkınma

19. The burden of chronic hepatitis B in a median endemic country:a mathematical approach

TOY M., ÖNDER F. O., İDİLMAN R., Richardus J. H., BOZDAYI A. M., KULOĞLU Z., et al.

International Liver Congress TM 2009. 44th Annual Meeting of The European Association for the Study of the Liver,Copenhagen, Denmark, 22-26 April, 200, Copenhag, Danimarka, 22 - 26 Nisan 2009, (Özet Bildiri)

20. TREATMENT OF HBEAG-POSITIVE CHRONIC DELTA HEPATITIS WITH NUCLEOS(T)IDE ANALOGS

Yurdaydin C., Bozkaya H., Heidrich B., Cakalogu Y., Deterding K., AKARCA U. S., et al.

59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Kostarika, 31 Ekim - 04 Kasım 2008, cilt.48, (Özet Bildiri) Sürdürülebilir Kalkınma

21. HBEAG-POSITIVE DELTA HEPATITIS: VIROLOGICAL; BIOCHEMICAL AND CLINICAL FEATURES IN A LARGE EUROPEAN MULTICENTER DATA BASE

Heidrich B., Wedemeyer H., Bektas M., İDİLMAN R., Oender F. O., BOZDAYI A. M., et al.

59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Kostarika, 31 Ekim - 04 Kasım 2008, cilt.48, (Özet Bildiri) Sürdürülebilir Kalkınma

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

456

H-İndeks (WoS)

Atıf (Scopus)

590

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Fikri Mülkiyet

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Fikri Mülkiyet

Tez Danışmanlığı

Açık Erişim